Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,023,441 papers from all fields of science
Search
Sign In
Create Free Account
clofilium
Known as:
Benzenebutanaminium, 4-Chloro-N,N-Diethyl-N-Heptyl
, (4-(P-Chlorophenyl)Butyl)Diethylheptylammonium
, Benzenebutanaminium, 4-chloro-N,N-diethyl-N-heptyl-
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Broader (3)
Anti-Arrhythmia Agents
Potassium Channel Blockers
Quaternary Ammonium Compounds
Clofilium Tosylate
clofilium phosphate
Narrower (1)
fluoroclofilium
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointes
Andrew J Batey
,
S. Coker
British Journal of Pharmacology
2002
Corpus ID: 7595378
This study was designed to compare the proarrhythmic activity of the antimalarial drug, halofantrine and the antihistamine…
Expand
Highly Cited
2002
Highly Cited
2002
Oxidant stress stimulates anion secretion from the human airway epithelial cell line calu‐3: implications for cystic fibrosis lung disease
E. Cowley
,
P. Linsdell
Journal of Physiology
2002
Corpus ID: 44330918
Exposure to reactive oxygen species (ROS) is associated with tissue damage in the lung and may be a common element in the…
Expand
Review
2001
Review
2001
Intracellular signalling involved in activation of the volume-sensitive K+ current in Ehrlich ascites tumour cells.
E. Hoffmann
,
C. Hougaard
Comparative biochemistry and physiology. Part A…
2001
Corpus ID: 35482851
1998
1998
Clofilium in the isolated perfused rabbit heart: A new model to study proarrhythmia induced by class III antiarrhythmic drugs
R. Johna
,
H. Mertens
,
+4 authors
G. Breithardt
Basic Research in Cardiology
1998
Corpus ID: 8634744
AbstractObjective: The clinical usefulness of class III antiarrhythmic drugs for the treatment of tachyarrhythmias is limited by…
Expand
1995
1995
Antiarrhythmic and bradycardic drugs inhibit currents of cloned K+ channels, KV1.2 and KV1.4.
T. Yamagishi
,
K. Ishii
,
N. Taira
European Journal of Pharmacology
1995
Corpus ID: 33295401
Highly Cited
1993
Highly Cited
1993
Comparative Assessment of Ibutilide, D‐Sotalol, Clofilium, E‐4031, and UK‐68, 798 in a Rabbit Model of Proarrhythmia
L. V. Buchanan
,
G. Kabell
,
M. Brunden
,
J. K. Gibson
Journal of Cardiovascular Pharmacology
1993
Corpus ID: 22895631
Summary Class III agents have been associated with development of a polymorphic ventricular tachycardia (PVT) known as torsades…
Expand
1991
1991
Oral clofilium produces sustained lowering of defibrillation energy requirements in a canine model.
P. Dorian
,
M. Wang
,
I. David
,
C. Feindel
Circulation
1991
Corpus ID: 25545743
The effect of long-term oral administration of antiarrhythmic drugs on defibrillation energy requirements is not well understood…
Expand
Highly Cited
1991
Highly Cited
1991
Cloning, expression, pharmacology and regulation of a delayed rectifier K+ channel in mouse heart.
Eric Honoré
,
Bernard Attali
,
+5 authors
J. Barhanin
EMBO Journal
1991
Corpus ID: 24122653
Neonatal mouse cardiac poly(A)+ mRNA microinjection into Xenopus oocytes directed the expression of a delayed rectifier K…
Expand
1991
1991
Cellular Electrophysiological Effects of the Class III Antiarrhythmic Agents Sematilide and Clofilium on Rabbit Atrial Tissues
T. Argentieri
,
M. S. Carroll
,
M. Sullivan
Journal of Cardiovascular Pharmacology
1991
Corpus ID: 40548249
Sematilide (N-[2-(diethylamino)ethyl]-4-[(methylsulfonyl)amino]benzamide HCl) is a new class III antiarrhythmic agent that has…
Expand
1984
1984
Dose‐ranging studies of clofilium, an antiarrhythmic quaternary ammonium
E. Platia
,
P. R. Reid
Clinical pharmacology and therapy
1984
Corpus ID: 26082201
Clofilium, a new quaternary ammonium antiarrhythmic without apparent ganglion‐blocking effect, was evaluated in 25 patients, 22…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE